These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 25492113)
1. Cannabinoids in experimental stroke: a systematic review and meta-analysis. England TJ; Hind WH; Rasid NA; O'Sullivan SE J Cereb Blood Flow Metab; 2015 Mar; 35(3):348-58. PubMed ID: 25492113 [TBL] [Abstract][Full Text] [Related]
2. Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review. England TJ; Gibson CL; Bath PM Brain Res Rev; 2009 Dec; 62(1):71-82. PubMed ID: 19751764 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. Kreutz S; Koch M; Ghadban C; Korf HW; Dehghani F Exp Neurol; 2007 Jan; 203(1):246-57. PubMed ID: 17010339 [TBL] [Abstract][Full Text] [Related]
4. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates. Suzuki N; Suzuki M; Murakami K; Hamajo K; Tsukamoto T; Shimojo M Brain Res; 2012 Jan; 1430():93-100. PubMed ID: 22119394 [TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of remote ischaemic conditioning in experimental stroke. Weir P; Maguire R; O'Sullivan SE; England TJ J Cereb Blood Flow Metab; 2021 Jan; 41(1):3-13. PubMed ID: 32538284 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of bumetanide in animal models of ischemic stroke: a systematic review and meta-analysis. Sun X; Hou J; Xu H; Qu H Aging (Albany NY); 2024 Jun; 16(11):9959-9971. PubMed ID: 38850525 [TBL] [Abstract][Full Text] [Related]
7. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Bath PM; Gray LJ; Bath AJ; Buchan A; Miyata T; Green AR; Br J Pharmacol; 2009 Aug; 157(7):1157-71. PubMed ID: 19422398 [TBL] [Abstract][Full Text] [Related]
8. The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis. Couch DG; Maudslay H; Doleman B; Lund JN; O'Sullivan SE Inflamm Bowel Dis; 2018 Mar; 24(4):680-697. PubMed ID: 29562280 [TBL] [Abstract][Full Text] [Related]
9. Progesterone treatment for experimental stroke: an individual animal meta-analysis. Wong R; Renton C; Gibson CL; Murphy SJ; Kendall DA; Bath PM; J Cereb Blood Flow Metab; 2013 Sep; 33(9):1362-72. PubMed ID: 23838830 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective antioxidants from marijuana. Hampson AJ; Grimaldi M; Lolic M; Wink D; Rosenthal R; Axelrod J Ann N Y Acad Sci; 2000; 899():274-82. PubMed ID: 10863546 [TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke. Sena E; Wheble P; Sandercock P; Macleod M Stroke; 2007 Feb; 38(2):388-94. PubMed ID: 17204689 [TBL] [Abstract][Full Text] [Related]
12. Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke. Ceprián M; Jiménez-Sánchez L; Vargas C; Barata L; Hind W; Martínez-Orgado J Neuropharmacology; 2017 Apr; 116():151-159. PubMed ID: 28012949 [TBL] [Abstract][Full Text] [Related]
13. The effect of rapamycin treatment on cerebral ischemia: A systematic review and meta-analysis of animal model studies. Beard DJ; Hadley G; Thurley N; Howells DW; Sutherland BA; Buchan AM Int J Stroke; 2019 Feb; 14(2):137-145. PubMed ID: 30489210 [TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of the efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in animal models of stroke. Liu J; Zhang C; Tao W; Liu M Int J Neurosci; 2013 Mar; 123(3):163-9. PubMed ID: 23167788 [TBL] [Abstract][Full Text] [Related]
16. Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial. Bustamante A; Giralt D; Garcia-Bonilla L; Campos M; Rosell A; Montaner J J Neurochem; 2012 Oct; 123(2):217-25. PubMed ID: 22845688 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Willmot M; Gibson C; Gray L; Murphy S; Bath P Free Radic Biol Med; 2005 Aug; 39(3):412-25. PubMed ID: 15993340 [TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of Ginsenoside-Rg1 (G-Rg1) in experimental ischemic stroke. Xie CL; Wang WW; Xue XD; Zhang SF; Gan J; Liu ZG Sci Rep; 2015 Jan; 5():7790. PubMed ID: 25600516 [TBL] [Abstract][Full Text] [Related]
19. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile. Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of antidepressants in animal models of ischemic stroke: a systematic review and meta-analysis. McCann SK; Irvine C; Mead GE; Sena ES; Currie GL; Egan KE; Macleod MR; Howells DW Stroke; 2014 Oct; 45(10):3055-63. PubMed ID: 25184357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]